跳至主要内容
临床试验/NCT02718599
NCT02718599已完成2 期

Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery

Assiut University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
1
主要终点
portal pressure changes

研究概览

简要总结

To evaluate the effect of terlipressin infusion on systemic and hepatic hemodynamics during hepatobiliary surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years.
  • Any gender.
  • ASA (American Society of Anesthesiologists) Classification( Class I-II)
  • Patients undergoing major elective hepatobiliary surgery.

排除标准

  • Preoperative renal failure (GFR < 50 ml/min).
  • Severe liver dysfunction (Child- turcotte -Pugh grade C).
  • Hyponatremia (<132 mmol/l).
  • Severe aortic regurgitation, severe mitral regurgitation, heart failure.
  • Symptomatic coronary heart disease.
  • Bradycardic arrhythmia (heart rate < 60/min).
  • Peripheral artery occlusive disease (clinical stadium II-IV).
  • Uncontrolled arterial hypertension (Blood pressure >160/100 mmHg despite intensive treatment).
  • Pregnancy.

研究组 & 干预措施

Terlipressin

Active Comparator

Terlipressin will be started at the beginning of surgery as an initial bolus dose of 1 mg over 30 mints(1 mg/50 ml normal saline at a rate of 100 ml/h) followed by a continuous infusion of 2 μg/kg/h(1 mg/50 ml at a rate equal to wt/10 ml per hour) and weaned in the postoperative period over 4 hours.

干预措施: terlipressin (Drug)

CONTROL

Placebo Comparator

Patients receive the same volume of 0.9% saline in place of terlipressin for the same duration(50 ml normal saline at a rate of 100 ml/h followed by a continuous infusion of 50 ml at a rate equal to wt/10 ml per hour and weaned in the postoperative period over 4 hours).

干预措施: normal saline (Drug)

结局指标

主要结局

portal pressure changes

时间窗: intraoperative period

portal pressure changes in mmHg

次要结局

  • Renal impairment(for 3 days in the postoperative period)
  • Effect on systemic vascular resistance(intraoperative period)
  • Blood units transfused(intraoperative period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Magdy Mohammed Mahdy Sayed

Effect of terlipressin and hepatic hemodynamics during hepatobiliary surgery infusion on systemic.

Assiut University

研究点 (1)

Loading locations...

相似试验